Holen Sie sich die Stockscreener-App
172.97
0.60%
0.88
Schlusskurs vom Vortag:
$172.09
Offen:
$171.46
24-Stunden-Volumen:
393.95K
Relative Volume:
0.32
Marktkapitalisierung:
$23.74B
Einnahmen:
$1.96B
Nettoeinkommen (Verlust:
$-253.24M
KGV:
-90.98
EPS:
-1.9012
Netto-Cashflow:
$94.06M
1W Leistung:
+8.06%
1M Leistung:
-1.85%
6M Leistung:
+13.91%
1J Leistung:
+35.80%
1-Tages-Spanne:
$171.02
$174.75
1-Wochen-Bereich:
$160.59
$174.75
52-Wochen-Spanne:
$117.27
$183.00
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Vergleichen Sie NTRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
172.99 | 23.62B | 1.96B | -253.24M | 94.06M | -1.9012 |
|
TMO
Thermo Fisher Scientific Inc
|
533.64 | 202.47B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
205.20 | 146.76B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
630.10 | 50.40B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
139.62 | 39.92B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.62 | 34.10B | 15.70B | 1.24B | 2.01B | 6.9036 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Natera, Inc. Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
Natera, Inc. $NTRA Position Increased by Narwhal Capital Management - MarketBeat
Can volume confirm reversal in Natera Inc.2025 Short Interest & Safe Swing Trade Setup Alerts - newser.com
QRG Capital Management Inc. Increases Position in Natera, Inc. $NTRA - MarketBeat
Natera Inc Stock Analysis and ForecastTrading Volume Surges & Compound Your Gains With Quality Stocks - earlytimes.in
Natera, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Truist Financial Corp Purchases 4,525 Shares of Natera, Inc. $NTRA - MarketBeat
What drives Natera Inc stock priceDividend Yield Trends & Low Cost Portfolio Ideas - earlytimes.in
Chart based exit strategy for Natera Inc.2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Why Natera Inc. stock remains on buy listsJuly 2025 Momentum & Verified Momentum Watchlists - newser.com
Is Natera Inc. building a consolidation base2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
Mirae Asset Global Investments Co. Ltd. Purchases 2,837 Shares of Natera, Inc. $NTRA - MarketBeat
How institutional ownership impacts Natera Inc. stockJuly 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com
Natera's Enrollment Surge in EXPAND Trial Could Be a Game Changer for Natera (NTRA) - simplywall.st
Combining machine learning predictions for Natera Inc.Market Weekly Review & Weekly Chart Analysis and Trade Guides - newser.com
Natera, Inc. $NTRA Shares Purchased by ASR Vermogensbeheer N.V. - MarketBeat
Barclays Keeps Their Buy Rating on Natera (NTRA) - The Globe and Mail
Natera (NTRA): Exploring Valuation as Share Price Pulls Back Despite Strong Growth - simplywall.st
Natera (NTRA): Assessing Valuation Potential as Shares Enter a Quiet Phase - simplywall.st
Is Natera Inc. a candidate for recovery play2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Natera Stock (NTRA) Opinions on EXPAND Trial Enrollment and Insider Sales - Quiver Quantitative
Natera (NASDAQ:NTRA) Insider Sells $479,970.00 in Stock - MarketBeat
Natera CEO Chapman sells $3.7m in stock By Investing.com - Investing.com Australia
Enrollment Tops 1,600 in Natera’s EXPAND Trial of Single Gene NIPT - BioSpace
Natera enrolls over 1,600 patients in EXPAND trial for fetal testing - Investing.com Nigeria
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 14,083 Shares of Stock - MarketBeat
Insider Sell: Solomon Moshkevich Sells 3,000 Shares of Natera In - GuruFocus
Natera (NTRA) sec. Rabinowitz sells $221k in shares By Investing.com - Investing.com Australia
Natera CFO Brophy sells $403,673 in shares By Investing.com - Investing.com South Africa
Natera CEO Chapman sells $3.7m in stock - Investing.com India
Natera (NTRA) sec. Rabinowitz sells $221k in shares - Investing.com India
Natera CFO Brophy sells $403,673 in shares - Investing.com India
Natera Inc: president Moshkevich sells $479k in stock By Investing.com - Investing.com South Africa
Natera Inc: president Moshkevich sells $479k in stock - Investing.com
Natera, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Why Natera’s Stock is Gaining Attention - TipRanks
Natera (NTRA) Achieves Key Enrollment Milestone in EXPAND Trial - GuruFocus
Natera enrolls over 1,600 patients in EXPAND trial for fetal testing By Investing.com - Investing.com South Africa
Ninety One UK Ltd Has $95.11 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer - BioSpace
Natera’s ctDNA test outperforms standard markers in testicular cancer By Investing.com - Investing.com Nigeria
Natera’s ctDNA test outperforms standard markers in testicular cancer - Investing.com India
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):